Oral immune regulation using colitis extracted proteins for treatment of Crohn&rsquo;s disease: Results of a phase I clinical trial

doi:10.3748/wjg.v11.i20.3105

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 11, Issue 20

This Article

(0)

(3951)

(13)

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

- Full Article with Cover (PDF)
- Full Article (XML)

Clinical Research

World J Gastroenterol. May 28, 2005; 11(20): 3105-3111
Published online May 28, 2005. doi: 10.3748/wjg.v11.i20.3105

Full Size Figure Download Figure

Figure 4 Peripheral NKT lymphocyte percent in 5/10 patients in whom a significant increase was observed during treatment. Baseline ratio (open bars) as compared to level of maximal increase (black bars, no. of week shown in parenthesis above each bar).

Citation: Israeli E, Goldin E, Shibolet O, Klein A, Hemed N, Engelhardt D, Rabbani E, Ilan Y. Oral immune regulation using colitis extracted proteins for treatment of Crohn’s disease: Results of a phase I clinical trial. World J Gastroenterol 2005; 11(20): 3105-3111
URL: https://www.wjgnet.com/1007-9327/full/v11/i20/3105.htm
DOI: https://dx.doi.org/10.3748/wjg.v11.i20.3105

Israeli E, Goldin E, Shibolet O, Klein A, Hemed N, Engelhardt D, Rabbani E, Ilan Y. Oral immune regulation using colitis extracted proteins for treatment of Crohn’s disease: Results of a phase I clinical trial. World J Gastroenterol 2005; 11(20): 3105-3111 [PMID: 15918198 DOI: 10.3748/wjg.v11.i20.3105]

All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.